Overview
bit.bio is a biotechnology company that develops proprietary technology to create reproducible, high-quality cell batches for pharmaceutical drug discovery and cell therapy applications. The company's platform enables life science researchers and biotech organizations to standardize cell type generation at scale, supporting high-throughput screening and advancing biotechnology research.
More in Neurotechnology
Latest industry news
Noninvasive Brain Interface Uses AI Suggestions to Triple Communication Speed
2026-11-21 · Research
Zhongke Borui Closes $15M Round to Scale Brain-Computer Interface Hardware in China
2026-11-20 · Funding
ALS Community Gains a Formal Voice in Brain-Computer Interface Development
2026-11-19 · Policy
Science Corporation Closes $400M Round to Push Brain-Computer Interface Technology Into the Clinic
2026-11-18 · Funding
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →